Increased risk of tuberculosis disease in people with diabetes mellitus: Record-linkage study in a UK population

Journal of Epidemiology and Community Health

Volumn 66, Issue 6, 2012, Pages 519-523

  Young, F ^a   Wotton, C J ^b   Critchley, J A ^c   Unwin, N C ^d   Goldacre, M J ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; DATA SET; DIABETES; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; DISEASE TREATMENT; HEALTH RISK; HOSPITAL SECTOR; PUBLIC HEALTH; RISK FACTOR; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIABETES MELLITUS; HUMAN; INFANT; MEDICAL RECORD; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK ASSESSMENT; TUBERCULOSIS; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; GREAT BRITAIN; HUMANS; INFANT; MEDICAL RECORD LINKAGE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TUBERCULOSIS; YOUNG ADULT;

UNITED KINGDOM;

EID: 84864023197     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2010.114595     Document Type: Article

References (36)

1. Morton R. Phthisiolgia: or a Treatise of Consumptions. London: Smith and Walford, 1694.
2. Department of Health. Stopping Tuberculosis in England: An Action Plan from the Chief Medical Officer. London: Department of Health, 2004.
3. Granich R, Binkin N, Jarvis W, et al. Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource Limited Settings. WHO Global Tuberculosis Programme. Geneva: World Health Organization, 1993.
4. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005.
5. IDF Clinical Guidelines Task Force. Global Guideline for Type 1 Diabetes. Brussels: International Diabetes Federation, 2005.
6. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536e48.
7. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 2000;55:887e901.
8. Maher D, Mikulencak M, Kochi A, et al. What is DOTS?-Guide to the WHO Recommended TB Control Strategy. Geneva, Switzerland: Communicable Diseases Cluster Prevention and Control, World Health Organization, International Union Against Tuberculosis and Lung Disease (IUATLD) The Royal Netherlands Tuberculosis Association (KNCV), 1999.
9. National Collaborating Centre for Chronic Conditions. Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (Update). London: Royal College of Physicians, 2008.
10. National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Clinical Excellence. Type 1 Diabetes: Diagnosis and Management of Type 1 Diabetes in Children and Young People. London: RCOG Press, 2004: Update 2008.
11. National Institute for Health and Clinical Excellence (NICE). Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and ControldNational Institute for Health and Clinical Excellence (NICE) Tuberculosis Clinical Guideline. London: Royal College of Physicians of London, 2006.
12. National Tuberculosis Centre. Annual Report of National Tuberculosis Control Programme. Kathmandu, Nepal: Ministry of Health, 2000/2001.
13. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000;55:210e18.
14. Tuberculosis Coalition for Technical Assistance. International Standards of Care. The Hague: Tuberculosis Coalition for Technical Assistance, 2006.
15. WHO. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report. Geneva: WHO, 2007.
16. WHO Global Tuberculosis Programme. Treatment Guidelines for National Programmes. 4th edn. WHO report. Geneva: WHO Press. 2003.
17. WHO Global Tuberculosis Programme. Tuberculosis and Air Travel: Guidelines for Prevention and Control. 3rd edn. WHO Report. Geneva: WHO Press, 2006.
18. Stevenson CR, Forouhi NG, Roglic G, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007;7:234.
19. Dooley KE, Tang T, Golub JE, et al. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009;80:634e9.
20. International Diabetes Federation. Diabetes Atlas, 2006.
21. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008;5:e152.
22. Al-Attiyah RJ, Mustafa AS. Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and nondiabetic tuberculosis patients and Mycobacterium bovis bacilli CalmetteeGuérin (BCG)-vaccinated healthy subjects. Clin Exp Immunol 2009;158:64e73.
23. Geerlings S, Hoepelman A. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999;26:259e65.
24. Tsukaguchi K, Yoneda T, Yoshikawa M. [Case study of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 production by peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis] (in Japanese). Kekkaku 1992;67:755e60.
25. Sreeramareddy C, Panduru K, Verma S, et al. Comparison of pulmonary and extrapulmonary tuberculosis in Nepal- a hospital-based retrospective study. BMC Infect Dis 2008;8:8.
26. Broxmeyer L. Diabetes mellitus, tuberculosis and the mycobacteria: two millenia of enigma. Med Hypotheses 2005;65:433e9.
27. Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007;3:228e45.
28. Mugusi F, Swai AB, Alberti KG, et al. Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 1990;71:271e6.
29. Fois AF, Wotton CJ, Yeates D, et al. Cancer in patients with motor neuron disease, multiple sclerosis, and Parkinson's disease: record-linkage studies. J Neurol Neurosurg Psychiatry 2010;81:215e21.
30. Goldacre M, Kurina L, Yeates D, et al. Use of large medical databases to study associations between diseases. QJM 2000;93:669e75.
31. Goldacre MJ, Wotton CJ, Seagroatt V, et al. Multiple sclerosis after infectious mononucleosis: Record linkage study. J Epidemiol Community Health 2004;58:1032e35.
32. Nienhuis H, Goldacre M, Seagroatt V, et al. Incidence of disease after vasectomy: A record linkage retrospective cohort study. BMJ 1992;304:743e46.
33. Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume II. The Design and Analysis of Cohort Studies. IARC Scientific Publication No. 82. Lyon: International Agency for Research in Cancer, 1987.
34. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. London: BMJ and RPS, 2008.
35. Bashar M, Alcabes P, Rom WN, et al. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue chest service, 1987 to 1997. Chest 2001;120:1514e19.
36. Restrepo BI, Fisher-Hoch SP, Smith B, et al. Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg 2008;79:541e4.